China has highest PD-1/PD-L1 combination immuno-oncology therapies clinical trials growth: GlobalData Read more
Dr Reddy’s to acquire select anti-allergy brands from Glenmark in Russia and other CIS countries Read more
FDA approval of Provention Bio’s Teplizumab could bring first disease-modifying therapy to type 1 diabetes space Read more
Half of top 20 global innovative pharma companies MCap reported positive growth in Q3 2020- GlobalData Read more